Phase 2 Trial of Glasdegib in Myelofibrosis Was Not Launched - Due to modest overall response in clinical activity - 101931

Spotlight
Video

Phase 2 Trial of Glasdegib in Myelofibrosis Was Not Launched - Due to modest overall response in clinical activity

ASHReport has 256 videos Subscribe Here

Loading........
Description: Aaron Gerds, MD from Cleveland Clinics discusses Phase 2 Trial of Glasdegib in myelofibrosis was not launched - due to modest overall response in clinical activity at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/26/18
Added : 7 months ago